VC Demo 2024

Pharmacogenomics: Optimizing Drug Therapy through Genetic Testing

Product not yet rated

  • Register
    • Non-member - $50
    • Member - $40
    • *Further discounts may apply once you log in.

    Continue

This presentation reviews emerging therapies for multiple sclerosis (MS), focusing on novel treatment approaches beyond disease-modifying agents. We discuss the potential of remyelination strategies, neuroprotective therapies, and immune-modulating agents in slowing disease progression and improving clinical outcomes for MS patients.

Key:

Complete
Failed
Available
Locked
Webinar
Select the "View On-Demand Webinar" button to begin.  |  45 minutes
Select the "View On-Demand Webinar" button to begin.  |  45 minutes
You must register to access.
Survey
3 Questions
3 Questions Rate 1 - 5
You must register to access.
Medical Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available
You must register to access.